Precision Oncology Account Executive (MRD)
Quest Diagnostics Incorporated | |
United States, Colorado, Denver | |
Oct 23, 2025 | |
|
Job Description
We Provide Solutions. Patients and Physicians rely on our diagnostic testing, information, and services to help them make better healthcare decisions. These are often serious decisions with far reaching consequences, and require sensitivity, tact, and a clear dedication to service. It's about providing clarity and hope. The Precision Oncology Account Executive is responsible for closing new business in the oncology specialized testing market. Precision Oncology Account Executive focuses on creating awareness, driving adoption, building complex molecular pathways, and generating demand and volume for Quest's precision oncology portfolio in community oncology and academic cancer centers. The Precision Oncology Account Executive works in close cooperation with oncology clinical, pathology and hospital account executives to support the collaborative selling model. This is a field-based sales position. At target, the compensation is $240,000 - $255,000. This includes a base salary and sales incentive. There is the potential to make higher, as the sales incentive is uncapped at Quest Diagnostics. Base salary offers are based on a wide range of factors including relevant skills, training, experience, education, and, where applicable, certifications obtained. Market and organizational factors are also considered. Responsibilities:
Qualifications: Required WorkExperience:
Knowledge and skills:
Bachelor's Degree Required 43619 Quest Diagnostics honors our service members and encourages veterans to apply. While we appreciate and value our staffing partners, we do not accept unsolicited resumes from agencies. Quest will not be responsible for paying agency fees for any individual as to whom an agency has sent an unsolicited resume. Equal Opportunity Employer: Race/Color/Sex/Sexual Orientation/Gender Identity/Religion/National Origin/Disability/Vets or any other legally protected status. | |
Oct 23, 2025